Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Journal of Clinical Lipidology
|
January 15, 2013
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies
Eli M Roth, Robert S Rosenson, Peter H Jones, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
February 9, 2010
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials
Peter H Jones, Kenneth Cusi, Michael H Davidson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 14, 2009
CD11c expression in adipose tissue and blood and its role in diet-induced obesity
Huaizhu Wu, Xiaoyuan Dai Perrard, Qun Wang, et al.
The American Journal of Cardiology
|
February 24, 2007
Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins
Bela F Asztalos, Florence Le Maulf, Gerald E Dallal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 3, 2005
Eotaxin and obesity
Abu R Vasudevan, Huaizhu Wu, Antonios M Xydakis, et al.
Journal of Lipid Research
|
December 2, 2008
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers
Thomas M van Himbergen, Nirupa R Matthan, Nancy A Resteghini, et al.
The American Journal of Cardiology
|
July 16, 2003
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)
Peter H Jones, Michael H Davidson, Evan A Stein, et al.
JAMA
|
September 8, 2005
Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trial
Michael Fordis, Jason E King, Christie M Ballantyne, et al.
Clinical Drug Investigation
|
September 12, 2008
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme
Peter H Jones, Harold E Bays, Michael H Davidson, et al.
Journal of Clinical Lipidology
|
January 29, 2013
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease
Smita I Negi, Ariel Brautbar, Salim S Virani, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Journal of Clinical Lipidology
|
January 15, 2013
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies
Eli M Roth, Robert S Rosenson, Peter H Jones, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
February 9, 2010
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials
Peter H Jones, Kenneth Cusi, Michael H Davidson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 14, 2009
CD11c expression in adipose tissue and blood and its role in diet-induced obesity
Huaizhu Wu, Xiaoyuan Dai Perrard, Qun Wang, et al.
The American Journal of Cardiology
|
February 24, 2007
Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins
Bela F Asztalos, Florence Le Maulf, Gerald E Dallal, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 3, 2005
Eotaxin and obesity
Abu R Vasudevan, Huaizhu Wu, Antonios M Xydakis, et al.
Journal of Lipid Research
|
December 2, 2008
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers
Thomas M van Himbergen, Nirupa R Matthan, Nancy A Resteghini, et al.
The American Journal of Cardiology
|
July 16, 2003
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)
Peter H Jones, Michael H Davidson, Evan A Stein, et al.
JAMA
|
September 8, 2005
Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trial
Michael Fordis, Jason E King, Christie M Ballantyne, et al.
Clinical Drug Investigation
|
September 12, 2008
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme
Peter H Jones, Harold E Bays, Michael H Davidson, et al.
Journal of Clinical Lipidology
|
January 29, 2013
A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease
Smita I Negi, Ariel Brautbar, Salim S Virani, et al.
Page
of 11